# FDA recall D-0244-2026

> **Novo Nordisk Inc.** · Class II · drug recall initiated 2025-12-19.

## Product

Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4505-14

## Reason for recall

Presence of Particulate Matter: Hair was found in a prefilled syringe

## Distribution

Nationwide within the United States.

## Key facts

- **Recall number:** D-0244-2026
- **Recalling firm:** Novo Nordisk Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2025-12-19
- **Report date:** 2026-01-07

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Plainsboro, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0244-2026

## Citation

> AI Analytics. FDA recall D-0244-2026. Retrieved 2026-06-09 from https://api.ai-analytics.org/recall/D-0244-2026. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*